Strata Critical Medical, Inc.
SRTANASDAQIndustrials● Active
$5.89
+$0.10(+1.68%)
Market Cap$509416528
P/E Ratio—
52W High$6.5
52W Low$3.51
Strata Critical Medical, Inc. (SRTA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · SRTA · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-09 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.20B | $0.25B | $0.23B | $0.15B | $0.05B |
| Cost of Revenue | $0.16B | $0.19B | $0.18B | $0.12B | $0.04B |
| Gross Profit | $0.04B | $0.06B | $0.04B | $0.02B | $0.01B |
| Gross Margin %(computed) | 19.44% | 23.69% | 18.71% | 15.24% | 20.82% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| G&A Expenses | $0.00B | $0.08B | $0.10B | $0.06B | $0.03B |
| Total Operating Expenses | $0.05B | $0.09B | $0.11B | $0.08B | $0.03B |
| Operating Income | ($0.01B) | ($0.03B) | ($0.07B) | ($0.05B) | ($0.02B) |
| Operating Margin %(computed) | -4.97% | -13.64% | -30.25% | -36.63% | -47.68% |
| Interest Income | $0.00B | $0.01B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.02B) | ($0.03B) | ($0.06B) | ($0.03B) | ($0.04B) |
| Income Tax Expense | $0.00B | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Net Income | ($0.02B) | ($0.03B) | ($0.06B) | ($0.03B) | ($0.04B) |
| Net Margin %(computed) | -7.94% | -10.98% | -24.90% | -18.66% | -79.27% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.19 | $-0.35 | $-0.76 | $-0.38 | $-0.57 |
| Wtd Avg Shares | 0.08B | 0.08B | 0.07B | 0.07B | 0.07B |
| EBITDA | ($0.00B) | ($0.03B) | ($0.06B) | ($0.07B) | ($0.02B) |
| EBITDA Margin %(computed) | -1.47% | -11.24% | -27.09% | -47.81% | -46.50% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Strata Critical Medical, Inc. data
About Strata Critical Medical, Inc. (SRTA) Income Statement
Strata Critical Medical, Inc. (SRTA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, SRTA reported revenue of $0.20B, gross profit of $0.04B (gross margin 19.44%), and net income of ($0.02B) — a net profit margin of -7.94%.
Frequently asked questions
SRTA · 4 questionsStrata Critical Medical, Inc. (SRTA) reported revenue of $0.20B for 2025, down 20.7% year-over-year.
SRTA revenueSRTA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08